Zobrazeno 1 - 10
of 112
pro vyhledávání: '"Elaine, Yu"'
Publikováno v:
Frontiers in Sports and Active Living, Vol 5 (2023)
BackgroundNon-professional climbers are increasingly attempting long routes in a single day. Many suffer injury or rely on search and rescue teams when they become too fatigued to finish. Predicting fatigue is difficult, and existing studies have onl
Externí odkaz:
https://doaj.org/article/1240c99800844851909df6c0eead60dc
Publikováno v:
JEM Reports. 2:100031
Autor:
Marquita Decker-Palmer, Chia-Wei Lin, Michele Wilson, Cheryl McDade, Komal Bawa, Stacey Kowal, Arliene Ravelo, Elaine Yu, Richard H. Ko
Publikováno v:
Blood. 140:13041-13042
Publikováno v:
Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
Osteonecrosis of the jaws (ONJ) occurs in patients on antiresorptive drugs for osteoporosis with the risk with oral bisphosphonates being known to be of the order of 0.1 to 0.3% while the risk for patients on denosumab for osteoporosis is not known.
Autor:
Liu, Raymond, Weldon, Christine B., Linehan, Elizabeth, Gordon, Nancy, Abbe, Thea, Hennings, Marti, James, Henie, Katzel, Jed, Chun Ng, Megumi Tomita, Velotta, Jeffrey B., Ossowski, Stephanie, Sakoda, Lori C., Sprague, Sharon Likely, Dowling, Anna, Beringer, Kimberly, Ravelo, Arliene, Elaine Yu, Trosman, Julia R.
Publikováno v:
JCO Oncology Practice; Jan2023, Vol. 19 Issue 1, pe125-e137, 13p
Autor:
Scott David Ramsey, Veena Shankaran, Aasthaa Bansal, Kaiyue Yu, Morgan Glascock, Karma L. Kreizenbeck, Kate Watabayashi, Richa Wilson, Annika Ittes, Canan Bilgin Keciciler, Avrita Campinha-Bacote, Wei Yu, Elaine Yu
Publikováno v:
Journal of Clinical Oncology. 40:444-444
444 Background: Almost half of the nearly 370,000 pts with cancer who receive chemotherapy in the United States each year experience Emergency Department (ED) visits and unplanned inpatient (IP) stays during treatment, largely due to poorly controlle
Autor:
Raymond Liu, Christine B. Weldon, Elizabeth Shurell Linehan, Nancy P. Gordon, Thea Abbe, Marti Hennings, Henie James, Jed Abraham Katzel, Chun Fai Ng, Megumi Tomita, Jeffrey B. Velotta, Stephanie Ossowski, Lori C. Sakoda, Sharon Sprague, Anna Dowling, Kimberly Beringer, Arliene Ravelo, Elaine Yu, Julia R. Trosman
Publikováno v:
Journal of Clinical Oncology. 40:57-57
57 Background: Delivering cancer care by high-functioning multidisciplinary teams promises to address care fragmentation and complexity, which threaten care quality, impact patient outcomes, and strain the oncology workforce. We assessed whether the
Autor:
Julia R. Trosman, Swati Kulkarni, Rachel Podrazik Baer, Lawrence Eric Feldman, Mary Pasquinelli, Sheetal Mehta Kircher, Al Bowen Benson, William John Gradishar, Bruce Rapkin, Della F. Makower, Claudia Beth Perez, Stephanie Boecher, Arliene Ravelo Mangalindan, Elaine Yu, Christine B. Weldon
Publikováno v:
Journal of Clinical Oncology. 40:344-344
1542 Background: The 4R Oncology model was proposed within the NCI ASCO Teams Project as an approach to facilitate patient-facing care planning, team-based delivery and patient self-management. 4R (Right Info/Care/Patient/Time) enables care teams and
Autor:
Scott David Ramsey, Veena Shankaran, Aasthaa Bansal, Kaiyue Yu, Morgan Glascock, Karma L. Kreizenbeck, Kate Watabayashi, Richa Wilson, Annika Ittes, Canan Bilgin Keciciler, Avrita Campinha-Bacote, Wei Yu, Elaine Yu
Publikováno v:
Journal of Clinical Oncology. 40:443-443
443 Background: Up to half of pts with cancer receiving systemic therapy have unplanned emergency department or hospital admission during treatment. ML41539 is a prospective observational study of an app to collect electronic patient-reported outcome
Autor:
Esprit Ma, Elaine Yu, Tania Szado, Richard Price, Craig S. Meyer, Anuj Shah, Baiyu Yang, Daniel Vaena, Davey Daniel, Dennis Slater, Harry Staszewski, Bruno Fang, Lasika Seneviratne, Lee Schwartzberg
Publikováno v:
Cancer Research. 82:2267-2267
Introduction: Biomarker testing identifies actionable mutations to inform targeted tx for personalized healthcare. This study examined biomarker testing and tx patterns ≤ 90 days (d) after advanced (adv) or metastatic (met) diagnosis (Dx) at the On